LEASELease • August 15th, 2016 • Mirna Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledAugust 15th, 2016 Company Industry
SEPARATION AGREEMENTSeparation Agreement • August 15th, 2016 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledAugust 15th, 2016 Company Industry JurisdictionThis Separation Agreement (the “Agreement”) by and between Miguel S. Barbosa, Ph.D. (“Executive”) and Mirna Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective eight (8) days after Executive’s signature hereto (the “Effective Date”), unless Executive revokes his acceptance of this Agreement as provided in Section 5(c) below, with reference to the following facts:
TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • August 15th, 2016 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledAugust 15th, 2016 Company Industry JurisdictionThis Transition and Separation Agreement (the “Agreement”) by and between Sinil Kim, M.D. (“Executive”) and Mirna Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective as of the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts: